Find uplifting stories about heroes, innovations, and solutions
10958 results for "type 2 diabetes"
People with Type 2 diabetes improved their blood sugar control with just four one-minute bursts of activity throughout the day. This simple "exercise snack" approach makes managing diabetes more accessible than ever.
A new study shows continuous glucose monitors significantly improve blood sugar control for Type 2 diabetics not on insulin, potentially opening access to life-changing technology for millions more people. Medicare coverage decision expected by year's end.
Chinese scientists used stem cell therapy to completely reverse type 2 diabetes in a patient for the first time ever. The breakthrough treatment eliminated the patient's need for insulin injections by regrowing healthy pancreatic cells.
Australia just approved the first treatment in 100 years that can delay type 1 diabetes before symptoms even appear. Teplizumab gives families precious extra time without insulin therapy, fear, and constant medical monitoring.
A groundbreaking insulin inhaler could soon spare millions of Type 1 diabetes patients from daily injections. The medical breakthrough offers new hope for easier diabetes management.
A cheap diabetes drug that's been around for 100 years is helping people with type 1 diabetes use significantly less insulin each day. Scientists are now racing to understand why it works so they can help even more patients.
A groundbreaking UK study reveals that stopping pre-diabetes through simple lifestyle changes could slash healthcare's carbon footprint by two-thirds while adding six years to people's lives. The findings show that preventing and managing diabetes properly isn't just good for patients—it's essential for reaching climate goals.
Australia just approved the first new type 1 diabetes therapy since insulin was discovered over a century ago. The treatment can delay disease progression by an average of two years, giving families precious time before daily insulin begins.
A groundbreaking clinical trial has freed all 12 Type 1 diabetes patients from daily insulin injections, with most achieving normal blood sugar in just 60 days. The combination of transplanted islet cells and a new drug called Tegoprubart could transform life for millions.
A groundbreaking triple-action weekly injection helped people with type 2 diabetes lose more than four times the weight of standard treatment while dramatically improving blood sugar control. The drug works differently than existing medications by targeting three hormones instead of one or two.
A groundbreaking UK screening program is catching type 1 diabetes in children before it becomes an emergency, preventing potentially fatal hospital crises. More than 37,000 families have already joined the effort that's transforming childhood diabetes care.
Stanford Medicine researchers reversed Type 1 diabetes in mice using a groundbreaking dual transplant that resets the immune system. The animals stayed diabetes-free for six months without insulin or immune suppressing drugs.
Two children at BC Children's Hospital became the first in Canada to receive a treatment that can delay type 1 diabetes by about two years. This marks a historic shift from just managing the disease to actually changing its course.
University of Chicago scientists developed a breakthrough mRNA therapy that protects insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts. Early tests in animals show the treatment successfully shields the cells that the disease destroys.
A groundbreaking treatment called teplizumab can delay type 1 diabetes by up to five years in high-risk patients, marking the first therapy that actually modifies the disease instead of just managing symptoms. Scientists are now racing to develop additional treatments that protect insulin-producing cells before they're destroyed.
Australia has approved Tzield, the first therapy in over 100 years that can delay the onset of type 1 diabetes by an average of two years. The breakthrough gives families precious time before the daily burden of insulin therapy begins.
Scientists at the University of Chicago have developed tiny particles that teach insulin-producing cells to protect themselves from autoimmune attack. The breakthrough could delay or prevent type 1 diabetes without suppressing the entire immune system.
Groundbreaking therapies combining stem cells and immune drugs are showing real promise in helping people with type 1 diabetes produce their own insulin again. One patient has already delayed disease progression for nearly a decade.
Scientists at the University of Chicago have developed a breakthrough nanoparticle system that delivers protective mRNA to insulin-producing cells, potentially preventing type 1 diabetes before it starts. The treatment worked in both mouse and human cells, offering hope for the 1.6 million Americans living with this autoimmune disease.
Researchers discovered a cellular clue that could help doctors spot type 1 diabetes before it fully develops. The breakthrough offers hope for catching and potentially stopping the disease earlier than ever before.
Showing 20 of 10958